Company Filing History:
Years Active: 2018
Title: Innovations in Cancer Treatment: The Contributions of Ede Laszlo Marvanyos
Introduction: Ede Laszlo Marvanyos is a prominent inventor based in Budapest, Hungary. He is recognized for his significant contribution to the pharmaceutical industry, particularly in the development of innovative compounds that aid in cancer treatment. With one patent to his name, Marvanyos showcases his dedication to advancing medical therapies through inventive solutions.
Latest Patents: Marvanyos holds a patent related to Dasatinib salts, a medication used in the treatment of various types of cancer. His patent encompasses the normal or acidic salts of dasatinib and various hydrate and solvate forms of the compound. Specifically, the invention includes dasatinib cyclamic acid salt, dasatinib cyclamic acid (1:1) salt Form I and Form II, dasatinib hydrogen bromide (1:2) salt, dasatinib methane sulfonic acid (1:2) salt, and dasatinib p-toluenesulfonic acid (1:1) dihydrate salt, among others. This patent not only includes the salts themselves but also covers the processes for preparing these dasatinib salts, pharmaceutical compositions comprising them, and their applications in cancer treatment.
Career Highlights: Marvanyos's career is distinguished by his role in developing vital pharmaceutical innovations. He contributes to Egis Gyogyszergyar Zrt., a leading pharmaceutical company in Hungary. His work there has positioned him as a critical player in the advancement of cancer therapies, showcasing a blend of scientific expertise and innovative thinking.
Collaborations: Throughout his career, Marvanyos has collaborated with notable colleagues, including Attila Virag and Tamas Gregor. These partnerships have been integral in fostering innovative solutions and driving research that leads to meaningful advancements in the field of medicine.
Conclusion: Ede Laszlo Marvanyos exemplifies the impact that dedicated inventors can have on the pharmaceutical industry. Through his patent on Dasatinib salts, he has made significant strides in the quest for effective cancer treatment options. His collaborations and career achievements at Egis Gyogyszergyar Zrt. demonstrate the power of innovation and teamwork in pushing the boundaries of medical science.